Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Its triple mechanism makes it particularly valuable for studying receptor crosstalk between GIP, GLP-1, and glucagon signalling pathways, and for examining how combined incretin and glucagon receptor activation modulates metabolic outcomes that single- and dual-agonist molecules cannot replicate
Terauchi, Y., Satoi, Y., Takeuchi, M
Its unique mechanism targets GLP-1 alongside glucagon receptor pathways, and studies examine its metabolic effects on energy expenditure, energy balance, glucose regulation, and gastric emptying
Additionally, new tools are being developed to monitor the responses of GLP-1 in the patient and to track the side effects associated with it
This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug for weight loss available in pill form, after Wegovy, which gained approval in December 2025
In blood, the elimination half-life is approximately 17.6 hours, suggesting that the erythrocyte mass may be a compartment of distribution
US$ 25.06
US$ 27.84
US$ 25.56
US$ 25.91
US$ 27.17
